Rational Advisors’s Repligen RGEN Stock Holding History

Rational Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-185	Closed	-$53K	–	199
2021 Q3	$53K	Sell	185 -55	-23%	-$14.1K	﹤0.01%	129
2021 Q2	$48K	Buy	+240	New	+$46.6K	0.01%	128

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Rational Advisors's RGEN Position: Q4 2021 in Review

Rational Advisors sold out of Repligen (RGEN) in Q4 2021, closing a stake of 185 shares — an estimated $53K sold.

Rational Advisors first reported a position in RGEN in Q2 2021 and held it in 2 quarters. The position peaked at $53K in Q3 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

Rational Advisors reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
Rational Advisors sold 185 Repligen shares in Q4 2021, an estimated $53K.
Rational Advisors first reported a position in Repligen in Q2 2021 and held it in 2 quarters.
Rational Advisors's Repligen position peaked at $53K in Q3 2021.
507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Rational Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.